Related Experiment Video

Updated: May 18, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

G/A polymorphism in intronic sequence affects the processing of MAO-B gene in patients with Parkinson disease

Egle Jakubauskiene1, Valda Janaviciute, Inga Peciuliene

  • 1Department of Immunology and Cell Biology, Vilnius University, Institute of Biotechnology, LT-02241 Vilnius, Lithuania.

FEBS Letters
|September 15, 2012
PubMed

Insights

Genetic variations in Monoamine oxidase B (MAO-B) intron 13 enhance its removal, potentially increasing MAO-B protein levels. This finding may offer a new biomarker for Parkinson's disease diagnosis.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Monoamine oxidase B (MAO-B) is crucial for metabolizing amines in the nervous system and tissues.
  • Elevated MAO-B mRNA and activity are observed in Parkinson's and Alzheimer's disease patients, but the cause is unclear.

Purpose of the Study:

  • To investigate the genetic triggers behind increased Monoamine oxidase B (MAO-B) mRNA levels in neurodegenerative diseases.
  • To explore the functional impact of genetic variations on MAO-B gene expression.

Main Methods:

  • Analysis of G/A dimorphism in intron 13 of the MAO-B gene.
  • Assessment of splicing efficiency and its effect on MAO-B mRNA and protein levels.

Main Results:

  • A G/A dimorphism in MAO-B intron 13 acts as a splicing enhancer.
  • This dimorphism significantly increases the efficiency of intron 13 removal.
  • The enhanced splicing leads to increased levels of MAO-B protein.

Conclusions:

  • The identified G/A dimorphism in MAO-B intron 13 is a key factor in elevating MAO-B expression.
  • Increased MAO-B protein levels due to this genetic variation may serve as a potential biomarker for Parkinson's disease.

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...